Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
7,711
archived clinical trials in
Depression

INSPIRE: Internet and Social-media Program With Information and Resources for Long-Term Cancer Survivors Who Underwent Stem Cell Transplant
INSPIRE for Survivorship After Transplant: A Multicenter Randomized Controlled Trial of an Internet and Social-Media Program for Long-Term Hematopoietic Cell Transplantation Survivors
Status: Enrolling
Updated:  1/30/2017
Univ of Nebraska Med Ctr
mi
from
Omaha, NE
INSPIRE: Internet and Social-media Program With Information and Resources for Long-Term Cancer Survivors Who Underwent Stem Cell Transplant
INSPIRE for Survivorship After Transplant: A Multicenter Randomized Controlled Trial of an Internet and Social-Media Program for Long-Term Hematopoietic Cell Transplantation Survivors
Status: Enrolling
Updated: 1/30/2017
Univ of Nebraska Med Ctr
mi
from
Omaha, NE
Click here to add this to my saved trials
INSPIRE: Internet and Social-media Program With Information and Resources for Long-Term Cancer Survivors Who Underwent Stem Cell Transplant
INSPIRE for Survivorship After Transplant: A Multicenter Randomized Controlled Trial of an Internet and Social-Media Program for Long-Term Hematopoietic Cell Transplantation Survivors
Status: Enrolling
Updated:  1/30/2017
University of Pennsylvania:Abramson Cancer Center
mi
from
Philadelphia, PA
INSPIRE: Internet and Social-media Program With Information and Resources for Long-Term Cancer Survivors Who Underwent Stem Cell Transplant
INSPIRE for Survivorship After Transplant: A Multicenter Randomized Controlled Trial of an Internet and Social-Media Program for Long-Term Hematopoietic Cell Transplantation Survivors
Status: Enrolling
Updated: 1/30/2017
University of Pennsylvania:Abramson Cancer Center
mi
from
Philadelphia, PA
Click here to add this to my saved trials
INSPIRE: Internet and Social-media Program With Information and Resources for Long-Term Cancer Survivors Who Underwent Stem Cell Transplant
INSPIRE for Survivorship After Transplant: A Multicenter Randomized Controlled Trial of an Internet and Social-Media Program for Long-Term Hematopoietic Cell Transplantation Survivors
Status: Enrolling
Updated:  1/30/2017
Moffitt Cancer Center
mi
from
Tampa, FL
INSPIRE: Internet and Social-media Program With Information and Resources for Long-Term Cancer Survivors Who Underwent Stem Cell Transplant
INSPIRE for Survivorship After Transplant: A Multicenter Randomized Controlled Trial of an Internet and Social-Media Program for Long-Term Hematopoietic Cell Transplantation Survivors
Status: Enrolling
Updated: 1/30/2017
Moffitt Cancer Center
mi
from
Tampa, FL
Click here to add this to my saved trials
INSPIRE: Internet and Social-media Program With Information and Resources for Long-Term Cancer Survivors Who Underwent Stem Cell Transplant
INSPIRE for Survivorship After Transplant: A Multicenter Randomized Controlled Trial of an Internet and Social-Media Program for Long-Term Hematopoietic Cell Transplantation Survivors
Status: Enrolling
Updated:  1/30/2017
Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center
mi
from
Cleveland, OH
INSPIRE: Internet and Social-media Program With Information and Resources for Long-Term Cancer Survivors Who Underwent Stem Cell Transplant
INSPIRE for Survivorship After Transplant: A Multicenter Randomized Controlled Trial of an Internet and Social-Media Program for Long-Term Hematopoietic Cell Transplantation Survivors
Status: Enrolling
Updated: 1/30/2017
Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center
mi
from
Cleveland, OH
Click here to add this to my saved trials
INSPIRE: Internet and Social-media Program With Information and Resources for Long-Term Cancer Survivors Who Underwent Stem Cell Transplant
INSPIRE for Survivorship After Transplant: A Multicenter Randomized Controlled Trial of an Internet and Social-Media Program for Long-Term Hematopoietic Cell Transplantation Survivors
Status: Enrolling
Updated:  1/30/2017
Fred Hutch/University of Washington Cancer Consortium
mi
from
Seattle, WA
INSPIRE: Internet and Social-media Program With Information and Resources for Long-Term Cancer Survivors Who Underwent Stem Cell Transplant
INSPIRE for Survivorship After Transplant: A Multicenter Randomized Controlled Trial of an Internet and Social-Media Program for Long-Term Hematopoietic Cell Transplantation Survivors
Status: Enrolling
Updated: 1/30/2017
Fred Hutch/University of Washington Cancer Consortium
mi
from
Seattle, WA
Click here to add this to my saved trials
Integrative Medicine Group Visits: A Patient-Centered Approach to Reducing Chronic Pain and Depression
Integrative Medicine Group Visits: A Patient-Centered Approach to Reducing Chronic Pain and Depression in a Disparate Urban Population
Status: Enrolling
Updated:  1/31/2017
Boston Med Ctr
mi
from
Boston, MA
Integrative Medicine Group Visits: A Patient-Centered Approach to Reducing Chronic Pain and Depression
Integrative Medicine Group Visits: A Patient-Centered Approach to Reducing Chronic Pain and Depression in a Disparate Urban Population
Status: Enrolling
Updated: 1/31/2017
Boston Med Ctr
mi
from
Boston, MA
Click here to add this to my saved trials
Ketamine for Suicidality in Bipolar Depression
Ketamine vs. Midazolam in Bipolar Depression
Status: Enrolling
Updated:  2/6/2017
Columbia University/New York State Psychiatric Institute
mi
from
New York, NY
Ketamine for Suicidality in Bipolar Depression
Ketamine vs. Midazolam in Bipolar Depression
Status: Enrolling
Updated: 2/6/2017
Columbia University/New York State Psychiatric Institute
mi
from
New York, NY
Click here to add this to my saved trials
An fMRI Study on Temporal Discounting in Bipolar Disorder
Reconceptualizing Suicide as Impaired Temporal Discounting: an fMRI Study in Bipolar Disorder
Status: Enrolling
Updated:  2/8/2017
Bipolar Clinic and Research Program at Massachusetts General Hospital
mi
from
Boston, MA
An fMRI Study on Temporal Discounting in Bipolar Disorder
Reconceptualizing Suicide as Impaired Temporal Discounting: an fMRI Study in Bipolar Disorder
Status: Enrolling
Updated: 2/8/2017
Bipolar Clinic and Research Program at Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Mindfulness-based Personalized Health Planning for Reducing Risk of Heart Disease and Diabetes
Mindfulness-based Personalized Health Planning for Reducing Risk of Heart Disease and Diabetes
Status: Enrolling
Updated:  2/23/2017
Duke Univ Med Ctr
mi
from
Durham, NC
Mindfulness-based Personalized Health Planning for Reducing Risk of Heart Disease and Diabetes
Mindfulness-based Personalized Health Planning for Reducing Risk of Heart Disease and Diabetes
Status: Enrolling
Updated: 2/23/2017
Duke Univ Med Ctr
mi
from
Durham, NC
Click here to add this to my saved trials
Study of NSI-189 for Major Depressive Disorder
A Phase 2, Double-Blind, Placebo-Controlled Study of NSI-189, a Neurogenic Compound Among Out-Patients With Major Depressive Disorder
Status: Enrolling
Updated:  2/23/2017
Midwest Clinical Research Center
mi
from
Dayton, OH
Study of NSI-189 for Major Depressive Disorder
A Phase 2, Double-Blind, Placebo-Controlled Study of NSI-189, a Neurogenic Compound Among Out-Patients With Major Depressive Disorder
Status: Enrolling
Updated: 2/23/2017
Midwest Clinical Research Center
mi
from
Dayton, OH
Click here to add this to my saved trials
Study of NSI-189 for Major Depressive Disorder
A Phase 2, Double-Blind, Placebo-Controlled Study of NSI-189, a Neurogenic Compound Among Out-Patients With Major Depressive Disorder
Status: Enrolling
Updated:  2/23/2017
Clinical Neuroscience Solutions, Inc
mi
from
Orlando, FL
Study of NSI-189 for Major Depressive Disorder
A Phase 2, Double-Blind, Placebo-Controlled Study of NSI-189, a Neurogenic Compound Among Out-Patients With Major Depressive Disorder
Status: Enrolling
Updated: 2/23/2017
Clinical Neuroscience Solutions, Inc
mi
from
Orlando, FL
Click here to add this to my saved trials
Study of NSI-189 for Major Depressive Disorder
A Phase 2, Double-Blind, Placebo-Controlled Study of NSI-189, a Neurogenic Compound Among Out-Patients With Major Depressive Disorder
Status: Enrolling
Updated:  2/23/2017
Clinical Neuroscience Solutions, Inc.
mi
from
Jacksonville, FL
Study of NSI-189 for Major Depressive Disorder
A Phase 2, Double-Blind, Placebo-Controlled Study of NSI-189, a Neurogenic Compound Among Out-Patients With Major Depressive Disorder
Status: Enrolling
Updated: 2/23/2017
Clinical Neuroscience Solutions, Inc.
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Study of NSI-189 for Major Depressive Disorder
A Phase 2, Double-Blind, Placebo-Controlled Study of NSI-189, a Neurogenic Compound Among Out-Patients With Major Depressive Disorder
Status: Enrolling
Updated:  2/23/2017
Institute for Advanced Medical Research
mi
from
Alpharetta, GA
Study of NSI-189 for Major Depressive Disorder
A Phase 2, Double-Blind, Placebo-Controlled Study of NSI-189, a Neurogenic Compound Among Out-Patients With Major Depressive Disorder
Status: Enrolling
Updated: 2/23/2017
Institute for Advanced Medical Research
mi
from
Alpharetta, GA
Click here to add this to my saved trials
Study of NSI-189 for Major Depressive Disorder
A Phase 2, Double-Blind, Placebo-Controlled Study of NSI-189, a Neurogenic Compound Among Out-Patients With Major Depressive Disorder
Status: Enrolling
Updated:  2/23/2017
Collaborative Neuroscience Network
mi
from
Garden Grove, CA
Study of NSI-189 for Major Depressive Disorder
A Phase 2, Double-Blind, Placebo-Controlled Study of NSI-189, a Neurogenic Compound Among Out-Patients With Major Depressive Disorder
Status: Enrolling
Updated: 2/23/2017
Collaborative Neuroscience Network
mi
from
Garden Grove, CA
Click here to add this to my saved trials
Study of NSI-189 for Major Depressive Disorder
A Phase 2, Double-Blind, Placebo-Controlled Study of NSI-189, a Neurogenic Compound Among Out-Patients With Major Depressive Disorder
Status: Enrolling
Updated:  2/23/2017
Synergy San Diego
mi
from
National City, CA
Study of NSI-189 for Major Depressive Disorder
A Phase 2, Double-Blind, Placebo-Controlled Study of NSI-189, a Neurogenic Compound Among Out-Patients With Major Depressive Disorder
Status: Enrolling
Updated: 2/23/2017
Synergy San Diego
mi
from
National City, CA
Click here to add this to my saved trials
Study of NSI-189 for Major Depressive Disorder
A Phase 2, Double-Blind, Placebo-Controlled Study of NSI-189, a Neurogenic Compound Among Out-Patients With Major Depressive Disorder
Status: Enrolling
Updated:  2/23/2017
Clinical trials of the Rockies, Inc.
mi
from
Denver, CO
Study of NSI-189 for Major Depressive Disorder
A Phase 2, Double-Blind, Placebo-Controlled Study of NSI-189, a Neurogenic Compound Among Out-Patients With Major Depressive Disorder
Status: Enrolling
Updated: 2/23/2017
Clinical trials of the Rockies, Inc.
mi
from
Denver, CO
Click here to add this to my saved trials
Study of NSI-189 for Major Depressive Disorder
A Phase 2, Double-Blind, Placebo-Controlled Study of NSI-189, a Neurogenic Compound Among Out-Patients With Major Depressive Disorder
Status: Enrolling
Updated:  2/23/2017
Psychiatric Medicine Associates
mi
from
Skokie, IL
Study of NSI-189 for Major Depressive Disorder
A Phase 2, Double-Blind, Placebo-Controlled Study of NSI-189, a Neurogenic Compound Among Out-Patients With Major Depressive Disorder
Status: Enrolling
Updated: 2/23/2017
Psychiatric Medicine Associates
mi
from
Skokie, IL
Click here to add this to my saved trials
Study of NSI-189 for Major Depressive Disorder
A Phase 2, Double-Blind, Placebo-Controlled Study of NSI-189, a Neurogenic Compound Among Out-Patients With Major Depressive Disorder
Status: Enrolling
Updated:  2/23/2017
St. Louis Clinical Trials, LC
mi
from
St. Louis, MO
Study of NSI-189 for Major Depressive Disorder
A Phase 2, Double-Blind, Placebo-Controlled Study of NSI-189, a Neurogenic Compound Among Out-Patients With Major Depressive Disorder
Status: Enrolling
Updated: 2/23/2017
St. Louis Clinical Trials, LC
mi
from
St. Louis, MO
Click here to add this to my saved trials
Study of NSI-189 for Major Depressive Disorder
A Phase 2, Double-Blind, Placebo-Controlled Study of NSI-189, a Neurogenic Compound Among Out-Patients With Major Depressive Disorder
Status: Enrolling
Updated:  2/23/2017
Richmond Behavioral Associates
mi
from
Staten Island, NY
Study of NSI-189 for Major Depressive Disorder
A Phase 2, Double-Blind, Placebo-Controlled Study of NSI-189, a Neurogenic Compound Among Out-Patients With Major Depressive Disorder
Status: Enrolling
Updated: 2/23/2017
Richmond Behavioral Associates
mi
from
Staten Island, NY
Click here to add this to my saved trials
Study of NSI-189 for Major Depressive Disorder
A Phase 2, Double-Blind, Placebo-Controlled Study of NSI-189, a Neurogenic Compound Among Out-Patients With Major Depressive Disorder
Status: Enrolling
Updated:  2/23/2017
FutureSearch Trials of Dallas
mi
from
Dallas, TX
Study of NSI-189 for Major Depressive Disorder
A Phase 2, Double-Blind, Placebo-Controlled Study of NSI-189, a Neurogenic Compound Among Out-Patients With Major Depressive Disorder
Status: Enrolling
Updated: 2/23/2017
FutureSearch Trials of Dallas
mi
from
Dallas, TX
Click here to add this to my saved trials
Study of NSI-189 for Major Depressive Disorder
A Phase 2, Double-Blind, Placebo-Controlled Study of NSI-189, a Neurogenic Compound Among Out-Patients With Major Depressive Disorder
Status: Enrolling
Updated:  2/23/2017
Clinical Trials of Texas, Inc.
mi
from
San Antonio, TX
Study of NSI-189 for Major Depressive Disorder
A Phase 2, Double-Blind, Placebo-Controlled Study of NSI-189, a Neurogenic Compound Among Out-Patients With Major Depressive Disorder
Status: Enrolling
Updated: 2/23/2017
Clinical Trials of Texas, Inc.
mi
from
San Antonio, TX
Click here to add this to my saved trials
Study of NSI-189 for Major Depressive Disorder
A Phase 2, Double-Blind, Placebo-Controlled Study of NSI-189, a Neurogenic Compound Among Out-Patients With Major Depressive Disorder
Status: Enrolling
Updated:  2/23/2017
Clinical NeuroScience Solutions, Inc.
mi
from
Memphis, TN
Study of NSI-189 for Major Depressive Disorder
A Phase 2, Double-Blind, Placebo-Controlled Study of NSI-189, a Neurogenic Compound Among Out-Patients With Major Depressive Disorder
Status: Enrolling
Updated: 2/23/2017
Clinical NeuroScience Solutions, Inc.
mi
from
Memphis, TN
Click here to add this to my saved trials
Treatment for Depression Among HIV-Infected Youth
Treatment for Depression Among HIV-Infected Youth
Status: Enrolling
Updated:  2/27/2017
USF College of Medicine
mi
from
Tampa, FL
Treatment for Depression Among HIV-Infected Youth
Treatment for Depression Among HIV-Infected Youth
Status: Enrolling
Updated: 2/27/2017
USF College of Medicine
mi
from
Tampa, FL
Click here to add this to my saved trials
Treatment for Depression Among HIV-Infected Youth
Treatment for Depression Among HIV-Infected Youth
Status: Enrolling
Updated:  2/27/2017
Montefiore Medical Center
mi
from
Bronx, NY
Treatment for Depression Among HIV-Infected Youth
Treatment for Depression Among HIV-Infected Youth
Status: Enrolling
Updated: 2/27/2017
Montefiore Medical Center
mi
from
Bronx, NY
Click here to add this to my saved trials
Treatment for Depression Among HIV-Infected Youth
Treatment for Depression Among HIV-Infected Youth
Status: Enrolling
Updated:  2/27/2017
Children's Hospital of Philadelphia
mi
from
Philadelphia, PA
Treatment for Depression Among HIV-Infected Youth
Treatment for Depression Among HIV-Infected Youth
Status: Enrolling
Updated: 2/27/2017
Children's Hospital of Philadelphia
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Treatment for Depression Among HIV-Infected Youth
Treatment for Depression Among HIV-Infected Youth
Status: Enrolling
Updated:  2/27/2017
St. Jude Children's Research Center
mi
from
Memphis, TN
Treatment for Depression Among HIV-Infected Youth
Treatment for Depression Among HIV-Infected Youth
Status: Enrolling
Updated: 2/27/2017
St. Jude Children's Research Center
mi
from
Memphis, TN
Click here to add this to my saved trials
Treatment of Maternal Depression in Home Visitation: Mother and Child Impacts
Treatment of Maternal Depression in Home Visitation: Mother and Child Impacts
Status: Enrolling
Updated:  2/28/2017
Cincinnati Children's Hospital Medical Center
mi
from
Cincinnati, OH
Treatment of Maternal Depression in Home Visitation: Mother and Child Impacts
Treatment of Maternal Depression in Home Visitation: Mother and Child Impacts
Status: Enrolling
Updated: 2/28/2017
Cincinnati Children's Hospital Medical Center
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Pharmacological Intervention in Depression After Traumatic Brain Injury
Pharmacological Intervention in Depression After Traumatic Brain Injury (A Research Study Within the Traumatic Brain Injury Model System)
Status: Enrolling
Updated:  3/16/2017
Virginia Commonwealth University
mi
from
Richmond, VA
Pharmacological Intervention in Depression After Traumatic Brain Injury
Pharmacological Intervention in Depression After Traumatic Brain Injury (A Research Study Within the Traumatic Brain Injury Model System)
Status: Enrolling
Updated: 3/16/2017
Virginia Commonwealth University
mi
from
Richmond, VA
Click here to add this to my saved trials
Examining Cognitive Mechanisms of Clinical Improvement Following Mindfulness Based Therapy for Depressed Individuals
Examining Cognitive Mechanisms of Clinical Improvement Following Mindfulness Based Cognitive Therapy for Depressed Individuals
Status: Enrolling
Updated:  3/21/2017
Massachusetts General Hospital
mi
from
Boston, MA
Examining Cognitive Mechanisms of Clinical Improvement Following Mindfulness Based Therapy for Depressed Individuals
Examining Cognitive Mechanisms of Clinical Improvement Following Mindfulness Based Cognitive Therapy for Depressed Individuals
Status: Enrolling
Updated: 3/21/2017
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Efficacy and Safety of Low Amplitude Electroconvulsive Therapy
Efficacy and Safety of Low Amplitude Electroconvulsive Therapy
Status: Enrolling
Updated:  3/21/2017
DukeUMC
mi
from
Durham, NC
Efficacy and Safety of Low Amplitude Electroconvulsive Therapy
Efficacy and Safety of Low Amplitude Electroconvulsive Therapy
Status: Enrolling
Updated: 3/21/2017
DukeUMC
mi
from
Durham, NC
Click here to add this to my saved trials
A Family-based Primary Care Intervention to Enhance Older Men's Depression Care
A Family-based Primary Care Intervention to Enhance Older Men's Depression Care
Status: Enrolling
Updated:  3/29/2017
San Joaquin General Hospital
mi
from
Stockton, CA
A Family-based Primary Care Intervention to Enhance Older Men's Depression Care
A Family-based Primary Care Intervention to Enhance Older Men's Depression Care
Status: Enrolling
Updated: 3/29/2017
San Joaquin General Hospital
mi
from
Stockton, CA
Click here to add this to my saved trials
Genecept Assay™ vs. Treatment-as-Usual to Evaluate Efficacy of Assay-Guided Treatment in Adults With MDD
An 8-Week Prospective Randomized, Controlled, Double-Blind Trial of the Genecept Assay ™ vs. Treatment-as-Usual to Evaluate Efficacy of Assay-Guided Treatment in Adults With Major Depressive Disorder (MDD)
Status: Enrolling
Updated:  3/30/2017
Woodland Research Northwest, LLC
mi
from
Springdale, AR
Genecept Assay™ vs. Treatment-as-Usual to Evaluate Efficacy of Assay-Guided Treatment in Adults With MDD
An 8-Week Prospective Randomized, Controlled, Double-Blind Trial of the Genecept Assay ™ vs. Treatment-as-Usual to Evaluate Efficacy of Assay-Guided Treatment in Adults With Major Depressive Disorder (MDD)
Status: Enrolling
Updated: 3/30/2017
Woodland Research Northwest, LLC
mi
from
Springdale, AR
Click here to add this to my saved trials
Genecept Assay™ vs. Treatment-as-Usual to Evaluate Efficacy of Assay-Guided Treatment in Adults With MDD
An 8-Week Prospective Randomized, Controlled, Double-Blind Trial of the Genecept Assay ™ vs. Treatment-as-Usual to Evaluate Efficacy of Assay-Guided Treatment in Adults With Major Depressive Disorder (MDD)
Status: Enrolling
Updated:  3/30/2017
Clinical Neuroscience Solutions Inc. - Jacksonville
mi
from
Jacksonville, FL
Genecept Assay™ vs. Treatment-as-Usual to Evaluate Efficacy of Assay-Guided Treatment in Adults With MDD
An 8-Week Prospective Randomized, Controlled, Double-Blind Trial of the Genecept Assay ™ vs. Treatment-as-Usual to Evaluate Efficacy of Assay-Guided Treatment in Adults With Major Depressive Disorder (MDD)
Status: Enrolling
Updated: 3/30/2017
Clinical Neuroscience Solutions Inc. - Jacksonville
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Genecept Assay™ vs. Treatment-as-Usual to Evaluate Efficacy of Assay-Guided Treatment in Adults With MDD
An 8-Week Prospective Randomized, Controlled, Double-Blind Trial of the Genecept Assay ™ vs. Treatment-as-Usual to Evaluate Efficacy of Assay-Guided Treatment in Adults With Major Depressive Disorder (MDD)
Status: Enrolling
Updated:  3/30/2017
Clinical Neuroscience Solutions Inc. - Orlando
mi
from
Orlando, FL
Genecept Assay™ vs. Treatment-as-Usual to Evaluate Efficacy of Assay-Guided Treatment in Adults With MDD
An 8-Week Prospective Randomized, Controlled, Double-Blind Trial of the Genecept Assay ™ vs. Treatment-as-Usual to Evaluate Efficacy of Assay-Guided Treatment in Adults With Major Depressive Disorder (MDD)
Status: Enrolling
Updated: 3/30/2017
Clinical Neuroscience Solutions Inc. - Orlando
mi
from
Orlando, FL
Click here to add this to my saved trials
Genecept Assay™ vs. Treatment-as-Usual to Evaluate Efficacy of Assay-Guided Treatment in Adults With MDD
An 8-Week Prospective Randomized, Controlled, Double-Blind Trial of the Genecept Assay ™ vs. Treatment-as-Usual to Evaluate Efficacy of Assay-Guided Treatment in Adults With Major Depressive Disorder (MDD)
Status: Enrolling
Updated:  3/30/2017
Chicago Research Center, Inc
mi
from
Chicago, IL
Genecept Assay™ vs. Treatment-as-Usual to Evaluate Efficacy of Assay-Guided Treatment in Adults With MDD
An 8-Week Prospective Randomized, Controlled, Double-Blind Trial of the Genecept Assay ™ vs. Treatment-as-Usual to Evaluate Efficacy of Assay-Guided Treatment in Adults With Major Depressive Disorder (MDD)
Status: Enrolling
Updated: 3/30/2017
Chicago Research Center, Inc
mi
from
Chicago, IL
Click here to add this to my saved trials
Genecept Assay™ vs. Treatment-as-Usual to Evaluate Efficacy of Assay-Guided Treatment in Adults With MDD
An 8-Week Prospective Randomized, Controlled, Double-Blind Trial of the Genecept Assay ™ vs. Treatment-as-Usual to Evaluate Efficacy of Assay-Guided Treatment in Adults With Major Depressive Disorder (MDD)
Status: Enrolling
Updated:  3/30/2017
Premier Psychiatric Research Institute, LLC
mi
from
Lincoln, NE
Genecept Assay™ vs. Treatment-as-Usual to Evaluate Efficacy of Assay-Guided Treatment in Adults With MDD
An 8-Week Prospective Randomized, Controlled, Double-Blind Trial of the Genecept Assay ™ vs. Treatment-as-Usual to Evaluate Efficacy of Assay-Guided Treatment in Adults With Major Depressive Disorder (MDD)
Status: Enrolling
Updated: 3/30/2017
Premier Psychiatric Research Institute, LLC
mi
from
Lincoln, NE
Click here to add this to my saved trials
Genecept Assay™ vs. Treatment-as-Usual to Evaluate Efficacy of Assay-Guided Treatment in Adults With MDD
An 8-Week Prospective Randomized, Controlled, Double-Blind Trial of the Genecept Assay ™ vs. Treatment-as-Usual to Evaluate Efficacy of Assay-Guided Treatment in Adults With Major Depressive Disorder (MDD)
Status: Enrolling
Updated:  3/30/2017
Richard H. Weisler & Associates
mi
from
Raleigh, NC
Genecept Assay™ vs. Treatment-as-Usual to Evaluate Efficacy of Assay-Guided Treatment in Adults With MDD
An 8-Week Prospective Randomized, Controlled, Double-Blind Trial of the Genecept Assay ™ vs. Treatment-as-Usual to Evaluate Efficacy of Assay-Guided Treatment in Adults With Major Depressive Disorder (MDD)
Status: Enrolling
Updated: 3/30/2017
Richard H. Weisler & Associates
mi
from
Raleigh, NC
Click here to add this to my saved trials
Genecept Assay™ vs. Treatment-as-Usual to Evaluate Efficacy of Assay-Guided Treatment in Adults With MDD
An 8-Week Prospective Randomized, Controlled, Double-Blind Trial of the Genecept Assay ™ vs. Treatment-as-Usual to Evaluate Efficacy of Assay-Guided Treatment in Adults With Major Depressive Disorder (MDD)
Status: Enrolling
Updated:  3/30/2017
Midwest Clinical Research Center
mi
from
Dayton, OH
Genecept Assay™ vs. Treatment-as-Usual to Evaluate Efficacy of Assay-Guided Treatment in Adults With MDD
An 8-Week Prospective Randomized, Controlled, Double-Blind Trial of the Genecept Assay ™ vs. Treatment-as-Usual to Evaluate Efficacy of Assay-Guided Treatment in Adults With Major Depressive Disorder (MDD)
Status: Enrolling
Updated: 3/30/2017
Midwest Clinical Research Center
mi
from
Dayton, OH
Click here to add this to my saved trials
Genecept Assay™ vs. Treatment-as-Usual to Evaluate Efficacy of Assay-Guided Treatment in Adults With MDD
An 8-Week Prospective Randomized, Controlled, Double-Blind Trial of the Genecept Assay ™ vs. Treatment-as-Usual to Evaluate Efficacy of Assay-Guided Treatment in Adults With Major Depressive Disorder (MDD)
Status: Enrolling
Updated:  3/30/2017
IPS Research Company
mi
from
Oklahoma City, OK
Genecept Assay™ vs. Treatment-as-Usual to Evaluate Efficacy of Assay-Guided Treatment in Adults With MDD
An 8-Week Prospective Randomized, Controlled, Double-Blind Trial of the Genecept Assay ™ vs. Treatment-as-Usual to Evaluate Efficacy of Assay-Guided Treatment in Adults With Major Depressive Disorder (MDD)
Status: Enrolling
Updated: 3/30/2017
IPS Research Company
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Genecept Assay™ vs. Treatment-as-Usual to Evaluate Efficacy of Assay-Guided Treatment in Adults With MDD
An 8-Week Prospective Randomized, Controlled, Double-Blind Trial of the Genecept Assay ™ vs. Treatment-as-Usual to Evaluate Efficacy of Assay-Guided Treatment in Adults With Major Depressive Disorder (MDD)
Status: Enrolling
Updated:  3/30/2017
Clinical Neuroscience Solutions, Inc. - Memphis
mi
from
Memphis, TN
Genecept Assay™ vs. Treatment-as-Usual to Evaluate Efficacy of Assay-Guided Treatment in Adults With MDD
An 8-Week Prospective Randomized, Controlled, Double-Blind Trial of the Genecept Assay ™ vs. Treatment-as-Usual to Evaluate Efficacy of Assay-Guided Treatment in Adults With Major Depressive Disorder (MDD)
Status: Enrolling
Updated: 3/30/2017
Clinical Neuroscience Solutions, Inc. - Memphis
mi
from
Memphis, TN
Click here to add this to my saved trials
Genecept Assay™ vs. Treatment-as-Usual to Evaluate Efficacy of Assay-Guided Treatment in Adults With MDD
An 8-Week Prospective Randomized, Controlled, Double-Blind Trial of the Genecept Assay ™ vs. Treatment-as-Usual to Evaluate Efficacy of Assay-Guided Treatment in Adults With Major Depressive Disorder (MDD)
Status: Enrolling
Updated:  3/30/2017
University of Alabama at Birmingham
mi
from
Birmingham, AL
Genecept Assay™ vs. Treatment-as-Usual to Evaluate Efficacy of Assay-Guided Treatment in Adults With MDD
An 8-Week Prospective Randomized, Controlled, Double-Blind Trial of the Genecept Assay ™ vs. Treatment-as-Usual to Evaluate Efficacy of Assay-Guided Treatment in Adults With Major Depressive Disorder (MDD)
Status: Enrolling
Updated: 3/30/2017
University of Alabama at Birmingham
mi
from
Birmingham, AL
Click here to add this to my saved trials
Genecept Assay™ vs. Treatment-as-Usual to Evaluate Efficacy of Assay-Guided Treatment in Adults With MDD
An 8-Week Prospective Randomized, Controlled, Double-Blind Trial of the Genecept Assay ™ vs. Treatment-as-Usual to Evaluate Efficacy of Assay-Guided Treatment in Adults With Major Depressive Disorder (MDD)
Status: Enrolling
Updated:  3/30/2017
Noesis Pharma
mi
from
Phoenix, AZ
Genecept Assay™ vs. Treatment-as-Usual to Evaluate Efficacy of Assay-Guided Treatment in Adults With MDD
An 8-Week Prospective Randomized, Controlled, Double-Blind Trial of the Genecept Assay ™ vs. Treatment-as-Usual to Evaluate Efficacy of Assay-Guided Treatment in Adults With Major Depressive Disorder (MDD)
Status: Enrolling
Updated: 3/30/2017
Noesis Pharma
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Genecept Assay™ vs. Treatment-as-Usual to Evaluate Efficacy of Assay-Guided Treatment in Adults With MDD
An 8-Week Prospective Randomized, Controlled, Double-Blind Trial of the Genecept Assay ™ vs. Treatment-as-Usual to Evaluate Efficacy of Assay-Guided Treatment in Adults With Major Depressive Disorder (MDD)
Status: Enrolling
Updated:  3/30/2017
Collaborative Neuroscience Network, Inc. - Garden Grove
mi
from
Garden Grove, CA
Genecept Assay™ vs. Treatment-as-Usual to Evaluate Efficacy of Assay-Guided Treatment in Adults With MDD
An 8-Week Prospective Randomized, Controlled, Double-Blind Trial of the Genecept Assay ™ vs. Treatment-as-Usual to Evaluate Efficacy of Assay-Guided Treatment in Adults With Major Depressive Disorder (MDD)
Status: Enrolling
Updated: 3/30/2017
Collaborative Neuroscience Network, Inc. - Garden Grove
mi
from
Garden Grove, CA
Click here to add this to my saved trials
Genecept Assay™ vs. Treatment-as-Usual to Evaluate Efficacy of Assay-Guided Treatment in Adults With MDD
An 8-Week Prospective Randomized, Controlled, Double-Blind Trial of the Genecept Assay ™ vs. Treatment-as-Usual to Evaluate Efficacy of Assay-Guided Treatment in Adults With Major Depressive Disorder (MDD)
Status: Enrolling
Updated:  3/30/2017
Pacific Institute for Medical Research Inc
mi
from
Los Angeles, CA
Genecept Assay™ vs. Treatment-as-Usual to Evaluate Efficacy of Assay-Guided Treatment in Adults With MDD
An 8-Week Prospective Randomized, Controlled, Double-Blind Trial of the Genecept Assay ™ vs. Treatment-as-Usual to Evaluate Efficacy of Assay-Guided Treatment in Adults With Major Depressive Disorder (MDD)
Status: Enrolling
Updated: 3/30/2017
Pacific Institute for Medical Research Inc
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Genecept Assay™ vs. Treatment-as-Usual to Evaluate Efficacy of Assay-Guided Treatment in Adults With MDD
An 8-Week Prospective Randomized, Controlled, Double-Blind Trial of the Genecept Assay ™ vs. Treatment-as-Usual to Evaluate Efficacy of Assay-Guided Treatment in Adults With Major Depressive Disorder (MDD)
Status: Enrolling
Updated:  3/30/2017
Pacific Research Partners, LLC
mi
from
Oakland, CA
Genecept Assay™ vs. Treatment-as-Usual to Evaluate Efficacy of Assay-Guided Treatment in Adults With MDD
An 8-Week Prospective Randomized, Controlled, Double-Blind Trial of the Genecept Assay ™ vs. Treatment-as-Usual to Evaluate Efficacy of Assay-Guided Treatment in Adults With Major Depressive Disorder (MDD)
Status: Enrolling
Updated: 3/30/2017
Pacific Research Partners, LLC
mi
from
Oakland, CA
Click here to add this to my saved trials
Genecept Assay™ vs. Treatment-as-Usual to Evaluate Efficacy of Assay-Guided Treatment in Adults With MDD
An 8-Week Prospective Randomized, Controlled, Double-Blind Trial of the Genecept Assay ™ vs. Treatment-as-Usual to Evaluate Efficacy of Assay-Guided Treatment in Adults With Major Depressive Disorder (MDD)
Status: Enrolling
Updated:  3/30/2017
Artemis Institute for Clinical Research
mi
from
San Diego, CA
Genecept Assay™ vs. Treatment-as-Usual to Evaluate Efficacy of Assay-Guided Treatment in Adults With MDD
An 8-Week Prospective Randomized, Controlled, Double-Blind Trial of the Genecept Assay ™ vs. Treatment-as-Usual to Evaluate Efficacy of Assay-Guided Treatment in Adults With Major Depressive Disorder (MDD)
Status: Enrolling
Updated: 3/30/2017
Artemis Institute for Clinical Research
mi
from
San Diego, CA
Click here to add this to my saved trials
Genecept Assay™ vs. Treatment-as-Usual to Evaluate Efficacy of Assay-Guided Treatment in Adults With MDD
An 8-Week Prospective Randomized, Controlled, Double-Blind Trial of the Genecept Assay ™ vs. Treatment-as-Usual to Evaluate Efficacy of Assay-Guided Treatment in Adults With Major Depressive Disorder (MDD)
Status: Enrolling
Updated:  3/30/2017
Collaborative Neuroscience Network, Inc. - Torrance
mi
from
Torrance, CA
Genecept Assay™ vs. Treatment-as-Usual to Evaluate Efficacy of Assay-Guided Treatment in Adults With MDD
An 8-Week Prospective Randomized, Controlled, Double-Blind Trial of the Genecept Assay ™ vs. Treatment-as-Usual to Evaluate Efficacy of Assay-Guided Treatment in Adults With Major Depressive Disorder (MDD)
Status: Enrolling
Updated: 3/30/2017
Collaborative Neuroscience Network, Inc. - Torrance
mi
from
Torrance, CA
Click here to add this to my saved trials
Genecept Assay™ vs. Treatment-as-Usual to Evaluate Efficacy of Assay-Guided Treatment in Adults With MDD
An 8-Week Prospective Randomized, Controlled, Double-Blind Trial of the Genecept Assay ™ vs. Treatment-as-Usual to Evaluate Efficacy of Assay-Guided Treatment in Adults With Major Depressive Disorder (MDD)
Status: Enrolling
Updated:  3/30/2017
Pacific Clinical Research Medical Group
mi
from
Upland, CA
Genecept Assay™ vs. Treatment-as-Usual to Evaluate Efficacy of Assay-Guided Treatment in Adults With MDD
An 8-Week Prospective Randomized, Controlled, Double-Blind Trial of the Genecept Assay ™ vs. Treatment-as-Usual to Evaluate Efficacy of Assay-Guided Treatment in Adults With Major Depressive Disorder (MDD)
Status: Enrolling
Updated: 3/30/2017
Pacific Clinical Research Medical Group
mi
from
Upland, CA
Click here to add this to my saved trials
Genecept Assay™ vs. Treatment-as-Usual to Evaluate Efficacy of Assay-Guided Treatment in Adults With MDD
An 8-Week Prospective Randomized, Controlled, Double-Blind Trial of the Genecept Assay ™ vs. Treatment-as-Usual to Evaluate Efficacy of Assay-Guided Treatment in Adults With Major Depressive Disorder (MDD)
Status: Enrolling
Updated:  3/30/2017
Florida Clinical Research Center, LLC - Bradenton
mi
from
Bradenton, FL
Genecept Assay™ vs. Treatment-as-Usual to Evaluate Efficacy of Assay-Guided Treatment in Adults With MDD
An 8-Week Prospective Randomized, Controlled, Double-Blind Trial of the Genecept Assay ™ vs. Treatment-as-Usual to Evaluate Efficacy of Assay-Guided Treatment in Adults With Major Depressive Disorder (MDD)
Status: Enrolling
Updated: 3/30/2017
Florida Clinical Research Center, LLC - Bradenton
mi
from
Bradenton, FL
Click here to add this to my saved trials
Genecept Assay™ vs. Treatment-as-Usual to Evaluate Efficacy of Assay-Guided Treatment in Adults With MDD
An 8-Week Prospective Randomized, Controlled, Double-Blind Trial of the Genecept Assay ™ vs. Treatment-as-Usual to Evaluate Efficacy of Assay-Guided Treatment in Adults With Major Depressive Disorder (MDD)
Status: Enrolling
Updated:  3/30/2017
Florida Clinical Research Center, LLC - Maitland
mi
from
Maitland, FL
Genecept Assay™ vs. Treatment-as-Usual to Evaluate Efficacy of Assay-Guided Treatment in Adults With MDD
An 8-Week Prospective Randomized, Controlled, Double-Blind Trial of the Genecept Assay ™ vs. Treatment-as-Usual to Evaluate Efficacy of Assay-Guided Treatment in Adults With Major Depressive Disorder (MDD)
Status: Enrolling
Updated: 3/30/2017
Florida Clinical Research Center, LLC - Maitland
mi
from
Maitland, FL
Click here to add this to my saved trials